According to TechSci Research's report, “United States Sex Reassignment Hormone Therapy Market – By Region, Competition, Forecast and Opportunities, 2029F,” the United States Sex Reassignment Hormone Therapy Market was valued at USD 1.21 billion in 2023 and is projected to grow at a CAGR of 4.29% through 2029. This growth reflects the increasing societal acceptance of...